These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 11935159

  • 1. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
    McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK, Gilbert RE.
    Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159
    [Abstract] [Full Text] [Related]

  • 2. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 3. Effects of pioglitazone on expressions of matrix metalloproteinases 2 and 9 in kidneys of diabetic rats.
    Dong FQ, Li H, Cai WM, Tao J, Li Q, Ruan Y, Zheng FP, Zhang Z.
    Chin Med J (Engl); 2004 Jul 20; 117(7):1040-4. PubMed ID: 15265379
    [Abstract] [Full Text] [Related]

  • 4. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.
    Nephrol Dial Transplant; 2006 Sep 20; 21(9):2406-16. PubMed ID: 16728425
    [Abstract] [Full Text] [Related]

  • 5. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
    Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Böhm M, Pauschinger M, Schultheiss HP, Tschöpe C.
    Basic Res Cardiol; 2008 Jul 20; 103(4):319-27. PubMed ID: 18347835
    [Abstract] [Full Text] [Related]

  • 6. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z.
    J Nephrol; 2007 Jul 20; 20(4):444-52. PubMed ID: 17879211
    [Abstract] [Full Text] [Related]

  • 7. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J, Markovic S, Wehland M, Melenhorst WB, van Goor H, Kreutz R.
    J Pharmacol Exp Ther; 2006 Jan 20; 316(1):8-16. PubMed ID: 16166267
    [Abstract] [Full Text] [Related]

  • 8. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
    Ding HL, Guo Y, Xu MT, Li HY, Fu ZZ.
    Chin Med J (Engl); 2007 Nov 05; 120(21):1886-9. PubMed ID: 18067760
    [Abstract] [Full Text] [Related]

  • 9. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ, Chen XM, Cui SW, Cai GY, Shi SZ, Xie YS, Lu Y, Peng LX.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):937-42. PubMed ID: 15329283
    [Abstract] [Full Text] [Related]

  • 10. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats.
    Martinez ML, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE.
    Eur J Pharmacol; 2008 Dec 03; 599(1-3):110-6. PubMed ID: 18930722
    [Abstract] [Full Text] [Related]

  • 11. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL, Catanzaro DF, Supino PG, Gupta A, Carter J, Herrold EM, Dumlao TF, Borer JS.
    Cardiology; 2009 Dec 03; 113(3):161-8. PubMed ID: 19129699
    [Abstract] [Full Text] [Related]

  • 12. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.
    J Lab Clin Med; 2004 Aug 03; 144(2):69-77. PubMed ID: 15322501
    [Abstract] [Full Text] [Related]

  • 13. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
    Eagleton MJ, Peterson DA, Sullivan VV, Roelofs KJ, Ford JA, Stanley JC, Upchurch GR.
    J Surg Res; 2002 May 01; 104(1):15-21. PubMed ID: 11971672
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb 01; 27(1):53-61. PubMed ID: 15782494
    [Abstract] [Full Text] [Related]

  • 15. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhonghua Yi Xue Za Zhi; 2004 Aug 02; 84(15):1288-93. PubMed ID: 15387968
    [Abstract] [Full Text] [Related]

  • 16. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
    Zhou J, Windsor LJ.
    J Periodontal Res; 2006 Feb 02; 41(1):47-54. PubMed ID: 16409255
    [Abstract] [Full Text] [Related]

  • 17. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R, Futterweit S, Valderrama E, Tarectecan AA, Bylander JE, Bond JS, Trachtman H.
    Am J Physiol Renal Physiol; 2005 Oct 02; 289(4):F911-21. PubMed ID: 15942051
    [Abstract] [Full Text] [Related]

  • 18. Expression of matrix metalloproteinase -2, -9 and tissue inhibitors of metalloproteinase -1, -2, -3 mRNAs in rat uterus during early pregnancy.
    Zhao YG, Xiao AZ, Cao XM, Zhu C.
    Mol Reprod Dev; 2002 Jun 02; 62(2):149-58. PubMed ID: 11984824
    [Abstract] [Full Text] [Related]

  • 19. Beneficial effects of C-peptide on renal morphology in diabetic rats.
    Sun W, Gao X, Zhao X, Cui D, Xia Q.
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec 02; 42(12):893-9. PubMed ID: 21106770
    [Abstract] [Full Text] [Related]

  • 20. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct 02; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.